Discover
AllergyTalk
AllergyTalk
Author: allergytalk
Subscribed: 26Played: 376Subscribe
Share
© Copyright 2019 All rights reserved.
Description
AllergyTalk delivers the latest insights and evidence shaping allergy and immunology. In each bimonthly episode, leading experts break down the most impactful research and real-world takeaways from AllergyWatch®, a bimonthly publication summarizing key findings from 20 major journals in allergy and asthma.
96 Episodes
Reverse
Today we are joined by Dr. Vivian Hernandez-Trujillo, the Division Director of Allergy/Immunology at Nicklaus Children’s Hospital, a Clinical Professor of Pediatrics at the Herbert Wertheim School of Medicine, and an assistant editor of Allergy Watch. We will be reviewing the May/June 2026 issue of Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology.
For those currently listening to the audio version, we are now releasing video versions of AllergyTalk as well! Please visit the ACAAI YouTube channel at https://www.youtube.com/allergists
For information about CME credit, head over to http://education.acaai.org/allergytalk
To read archived issues of AllergyWatch, head over to http://college.acaai.org/publications/allergywatch
Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles!
Articles Reviewed:
HPV vaccination is associated with lower risk of cancers among females.
Association of muscle instability and long-term prophylaxis in hereditary angioedema.
Prime Editing for p47(phox)-Deficient Chronic Granulomatous Disease.
Recent article on TriNetX studies: https://www.science.org/content/article/medical-students-are-using-popular-research-tool-pump-out-misleading-studies
NYTimes article discussing the economics of gene therapy for rare diseases: https://www.nytimes.com/2025/09/22/health/gene-editing-rare-diseases-fda.html
Please rate our podcast on Apple Podcasts and YouTube!
Please give us feedback, corrections, and suggestions!
Email feedback to: [email protected]
ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.
Today we are joined by Dr. Vivian Hernandez-Trujillo, the Division Director of Allergy/Immunology at Nickalus Children’s Hospital, a Clinical Professor of Pediatrics at the Herbert Wertheim School of Medicine, and an assistant editor of Allergy Watch. We will be reviewing the May/June 2026 issue of Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology.
For those currently listening to the audio version, we are now releasing video versions of AllergyTalk as well! Please visit the ACAAI YouTube channel at https://www.youtube.com/allergists
For information about CME credit, head over to http://education.acaai.org/allergytalk
To read archived issues of AllergyWatch, head over to http://college.acaai.org/publications/allergywatch
Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles!
Articles Reviewed:
Identifying gaps: A survey of food allergy knowledge and management in US adults.
Prevalence of KIT D816V in anaphylaxis or systemic mast cell activation.
Fresh clothes, hard breaths: Laundry washing habits, detergents, softeners, and impaired respiratory functions in children with wheezing.
NIH calculator: https://bst-calculater.niaid.nih.gov
Please rate our podcast on Apple Podcasts and YouTube!
Please give us feedback, corrections, and suggestions!
Email feedback to: [email protected]
ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.
Today we are joined by Dr. Sarah Spriet, a Staff Allergist and Clinical Immunologist at Alexander T. Augusta Military Medical Center in Northern Virginia and an assistant editor of Allergy Watch. We will be reviewing the January/February 2026 issue of Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology.
For those currently listening to the audio version, we are now releasing video versions of AllergyTalk as well! Please visit the ACAAI YouTube channel at https://www.youtube.com/allergists
For information about CME credit, head over to http://education.acaai.org/allergytalk
To read archived issues of AllergyWatch, head over to http://college.acaai.org/publications/allergywatch
Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles!
Articles Reviewed:
SQ House Dust Mite Sublingual Immunotherapy Tablet in Children With Allergic Asthma: A Randomised Phase III Trial.
Stock Inhalers in Chicago Public Schools: Using the RE-AIM Framework to Assess Impact.
Type 2 cytokines pleiotropically modulate sensory nerve architecture and neuroimmune interactions to mediate itch.
Welcome to another episode of Allergy Talk, a roundup of the latest in the field of Allergy and Immunology by the American College of Allergy, Asthma, and Immunology. For today’s episode we will be reviewing articles from Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology.
Today we joined by Dr. Sarah, Spriet, a Staff Allergist and Clinical Immunologist at Alexander T. Augusta Military Medical Center in Northern Virginia and an assistant editor of Allergy Watch. We will be reviewing the January/February 2026 issue Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology.
To read archived issues of Allergy Watch, head over to https://college.acaai.org/publications/allergywatch. Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles!
Articles Reviewed:
A proof-of-mechanism trial in asthma with lunsekimig, a bispecific NANOBODYmolecule.
Comparative efficacy and safety of biologics and systemic immunomodulatory treatments for chronic urticaria: Systematic review and network meta-analysis
Food allergy clinical course in children and adolescents treated with dupilumab for atopic dermatitis.
ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.
Welcome to another episode of Allergy Talk, a roundup of the latest in the field of Allergy and Immunology by the American College of Allergy, Asthma, and Immunology. For today’s episode we will be reviewing articles from Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology.
Today we joined by Dr. Shyam Joshi, an associate professor and Section Chief at Oregon Health & Science University and Associate Editor of Allergy Watch! We will be reviewing the November-December 2025 issue Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology.
To read archived issues of Allergy Watch, head over to https://college.acaai.org/publications/allergywatch. Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles!
Articles Reviewed:
Food-Induced Anaphylaxis: Data From the European Anaphylaxis Registry
Introduction of allergenic foods after treatment with omalizumab
Azelastine Nasal Spray for Prevention of SARS-CoV-2 Infections: A Phase 2 Randomized Clinical Trial.
ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.



